Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short‐ and long‐acting glucagon‐like peptide‐1 receptor agonists in type 2 diabetes
Aim To clarify the distinct effects of a long‐acting (liraglutide) and a short‐acting (lixisenatide) glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) on macronutrient intake, gastrointestinal side effects and pancreas function. Materials and Methods Fifty participants were randomized to either li...
Gespeichert in:
Veröffentlicht in: | Diabetes, obesity & metabolism obesity & metabolism, 2021-10, Vol.23 (10), p.2344-2353 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!